跳至主要内容
临床试验/NCT04048252
NCT04048252已完成不适用

Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy: Construction and Feasibility Study

Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2019年9月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Create a focus group

研究概览

简要总结

The development of a personalized therapeutic education program dedicated to patients with metastatic prostate cancer and receiving next-generation hormone therapy would improve their knowledge of the disease, medication adherence and quality of life.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with metastatic prostate cancer treated with enzalutamide or abiraterone acetate for at least 3 months
  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be insured or the beneficiary of an insurance policy

排除标准

  • The subject is not in a fit state to express their consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

研究组 & 干预措施

Focus group

干预措施: Focus group creation (Other)

Workshop

干预措施: Workshop (Other)

结局指标

主要结局

Create a focus group

时间窗: Day 0

Transcribe interview and mark key points

Patient satisfaction

时间窗: End of workshops (max 2 months)

Yes/no

Successful running of workshop

时间窗: End of workshops (max 2 months)

Yes/no evaluated by the workshop leader

次要结局

  • Patient quality of life(1 month after last workshop)
  • Patient knowledge of their disease(End of workshops (max 2 months))
  • Patient-reported satisfaction of programme(End of workshops (max 2 months))
  • Patient-reported acceptability of programme(End of workshops (max 2 months))
  • Patient medication adherence(End of workshops (max 2 months))
  • Patient participation rate in workshops(End of workshops (max 2 months))

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验